Literature DB >> 11917948

GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy.

J O Fernberg1, O Brosjö, S Friesland, G Masucci.   

Abstract

Combinations of radiotherapy and surgery are often used in local cancer treatments. Preoperative radiotherapy may delay wound healing after surgery. Chronic wounds are debilitating conditions that require frequent medical attention. Two patients suffering from chronic and slowly healing wounds post-surgery and preoperative radiotherapy are described. A significant acceleration of the healing by local injections with GM-CSF was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11917948     DOI: 10.1385/MO:18:3:231

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  8 in total

Review 1.  Modern therapy of chronic wounds with respect to radiation.

Authors:  J Frank; J H Barker; I Marzi; W Mutschler
Journal:  Strahlenther Onkol       Date:  1998-11       Impact factor: 3.621

2.  Wound healing following radiation therapy: a review.

Authors:  M K Tibbs
Journal:  Radiother Oncol       Date:  1997-02       Impact factor: 6.280

3.  Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing.

Authors:  I Ure; B Partsch; K Wolff; P Petzelbauer
Journal:  Br J Dermatol       Date:  1998-02       Impact factor: 9.302

Review 4.  New clinical applications of granulocyte-macrophage colony-stimulating factor.

Authors:  G Masucci
Journal:  Med Oncol       Date:  1996-09       Impact factor: 3.064

5.  Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.

Authors:  W E Berdel; S Danhauser-Riedl; G Steinhauser; E F Winton
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

6.  Complications of postoperative and preoperative radiation therapy in head and neck cancers. A comparative study.

Authors:  R V Mantravadi; E M Skolnik; E L Applebaum
Journal:  Arch Otolaryngol       Date:  1981-11

Review 7.  In vitro assessment of the effects of granulocyte-macrophage colony-stimulating factor on primary human tumors and derived lines.

Authors:  R S Foulke; M H Marshall; P P Trotta; D D Von Hoff
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

8.  Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.

Authors:  G Kaplan; G Walsh; L S Guido; P Meyn; R A Burkhardt; R M Abalos; J Barker; P A Frindt; T T Fajardo; R Celona
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

  8 in total
  2 in total

1.  Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study.

Authors:  Giuseppe Masucci; Peter Broman; Charles Kelly; Sten Lindahl; Lena Malmberg; Johan Reizenstein; Martin Alenius; Rolf Lewensohn
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

2.  A new rabbit model of impaired wound healing in an X-ray-irradiated field.

Authors:  Kazutoshi Fujita; Soh Nishimoto; Toshihiro Fujiwara; Yohei Sotsuka; Maki Tonooka; Kenichiro Kawai; Masao Kakibuchi
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.